21Vita Overview
- Year Founded
-
2009
- Status
-
Public
- Employees
-
710
- Stock Symbol
-
301507
- Investments
-
2
- Share Price
-
$1.71
- (As of Friday Closing)
21Vita General Information
Description
Hangzhou Minsheng Healthcare Co Ltd focuses on the field of vitamin and mineral supplements and is a high-tech enterprise integrating research and development, production and sales of vitamin and mineral over-the-counter drugs and health food. The company's current main product is 21 Golden Vita multi-dimensional element tablets (21).
Contact Information
Website
www.21vita.comCorporate Office
- No. 101, Xintian Road
- Yuhang Economic and Technological Development Zone
- Hangzhou, Zhejiang
- China
Corporate Office
- No. 101, Xintian Road
- Yuhang Economic and Technological Development Zone
- Hangzhou, Zhejiang
- China
21Vita Stock Performance
As of 13-Nov-2026, 21Vita’s stock price is $1.71. Its current market cap is $611M with 357M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.71 | $1.75 | $1.65 - $2.71 | $611M | 357M | 4.53M | $0.04 |
21Vita Financials Summary
As of 30-Sep-2026, 21Vita has a trailing 12-month revenue of $131M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 611,537 | 682,698 | 512,141 | 696,451 |
| Revenue | 130,953 | 108,691 | 89,367 | 82,225 |
| EBITDA | 13,664 | 21,892 | 15,374 | 16,188 |
| Net Income | 12,859 | 16,519 | 12,798 | 12,104 |
| Total Assets | 312,306 | 288,286 | 238,984 | 232,459 |
| Total Debt | 408 | 399 | 143 | 301 |
21Vita Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
21Vita Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
21Vita Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
21Vita Investments (2)
21Vita’s most recent deal was a Later Stage VC with Earendil Labs for . The deal was made on 20-Mar-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Earendil Labs | 20-Mar-2026 | Later Stage VC | Discovery Tools (Healthcare) | ||
| Scienpharm | 31-Dec-2023 | Later Stage VC | Pharmaceuticals |
21Vita ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
21Vita FAQs
-
When was 21Vita founded?
21Vita was founded in 2009.
-
Where is 21Vita headquartered?
21Vita is headquartered in Hangzhou, China.
-
What is the size of 21Vita?
21Vita has 710 total employees.
-
What industry is 21Vita in?
21Vita’s primary industry is Other Consumer Non-Durables.
-
Is 21Vita a private or public company?
21Vita is a Public company.
-
What is 21Vita’s stock symbol?
The ticker symbol for 21Vita is 301507.
-
What is the current stock price of 21Vita?
As of 13-Nov-2026 the stock price of 21Vita is $1.71.
-
What is the current market cap of 21Vita?
The current market capitalization of 21Vita is $611M.
-
What is 21Vita’s current revenue?
The trailing twelve month revenue for 21Vita is $131M.
-
What is 21Vita’s annual earnings per share (EPS)?
21Vita’s EPS for 12 months was $0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
